OmniSonics Medical Technologies

About:

OmniSonics Medical Technologies is a U.S.-based company that develops medical devices used in the treatment of vascular occlusive diseases.

Website: http://www.omnisonics.com/

Top Investors: Canaan Partners, Domain Associates, Johnson & Johnson Development Corporation, Prism Venture Management, Mitsubishi International Corporation (MIC)

Description:

OmniSonics Medical Technologies is a U.S.-based company that develops medical devices used in the treatment of vascular occlusive diseases. Its products are designed to deliver transverse, ultrasonic energy along the length of a small diameter wire to an artery or vein that has been obstructed by thrombus. OmniSonics Medical Technologies uses low power ultrasonic energy to create cavitational streaming that rapidly dissolves thrombus and quickly restores blood flow without adversely damaging surrounding vessel walls. Its current commercial product, the OmniWave Endovascular System is indicated to infuse physician-specified fluids and remove thrombus in the peripheral vasculature. The company is headquartered in Lakewood, New York.

Total Funding Amount:

$89.7M

Headquarters Location:

Lakewood, New York, United States

Founded Date:

1998-01-01

Contact Email:

info(AT)omnisonics.com

Founders:

Number of Employees:

51-100

Last Funding Date:

2007-07-19

IPO Status:

Private

Industries:

© 2025 bioDAO.ai